Previous close | 11.29 |
Open | 11.31 |
Bid | 11.29 x 100 |
Ask | 11.33 x 100 |
Day's range | 11.31 - 11.31 |
52-week range | 10.40 - 11.35 |
Volume | |
Avg. volume | 42,391 |
Market cap | 85.238M |
Beta (5Y monthly) | -0.00 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.22 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Adagio Medical, Inc. ("Adagio Medical"), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, and ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) ("ARYA"), a special purpose acquisition company that is sponsored by an affiliate of Perceptive Advisors, LLC ("Perceptive Advisors"), today announced they have entered a definitive agreement (the "business combination agreement") for a business combination (the "transaction"). Upon closing of the transaction, Ad
In this article, we discuss Farallon Capital: a global and diversified hedge fund and its top stock picks. If you want to skip our detailed analysis of these stocks, go directly to the Top 5 Stock Picks of Farallon Capital. Risk arbitrage or merger arbitrage is one of the most popular strategies that hedge funds […]